Literature DB >> 28139293

Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.

Sanjeev Sethi1, Surendra Dasari2, Md Shahrier Amin3, Julie A Vrana3, Jason D Theis3, Mariam P Alexander3, Paul J Kurtin3.   

Abstract

Gelsolin amyloidosis is a rare type of amyloidosis typically involving the cranial and peripheral nerves, but rarely the kidney. Here we report the clinical, kidney biopsy, and mass spectrometry findings in 12 cases of renal gelsolin amyloidosis. Of the 12 patients, five were men and seven were women with mean age at diagnosis of 63.8 years. Gelsolin amyloidosis was most common in Caucasians (six patients) and Asians (four patients), and included one each African-American and Hispanic patients. Nephrotic syndrome was the most common cause of biopsy, although most patients also had progressive loss of kidney function. Hematological and serological evaluation was negative in 11 patients, while one patient had a monoclonal gammopathy. The renal biopsy showed large amounts of pale eosinophilic Congo red-positive amyloid deposits typically restricted to the glomeruli. Immunofluorescence studies were negative for immunoglobulins in nine cases with three cases of smudgy glomerular staining for IgG. Electron microscopy showed mostly random arrangement of amyloid fibrils with focally parallel bundles/sheets of amyloid fibrils present. Laser microdissection of the amyloid deposits followed by mass spectrometry showed large spectra numbers for gelsolin, serum amyloid P component, and apolipoproteins E and AIV. Furthermore, the p. Asn211Lys gelsolin mutation on mass spectrometry studies was detected in three patients by mass spectrometry, which appears to represent a renal-limited form of gelsolin amyloidosis. Thus, renal gelsolin amyloidosis is seen in older patients, presents with nephrotic syndrome and progressive chronic kidney disease, and histologically exhibits glomerular involvement. The diagnosis can be confirmed by mass spectrometry studies.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amyloid; gelsolin; kidney; laser microdissection; mass spectrometry

Mesh:

Substances:

Year:  2017        PMID: 28139293     DOI: 10.1016/j.kint.2016.11.017

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Pathology and diagnosis of renal non-AL amyloidosis.

Authors:  Sanjeev Sethi; Jason D Theis
Journal:  J Nephrol       Date:  2017-08-21       Impact factor: 3.902

2.  Gelsolin pathogenic Gly167Arg mutation promotes domain-swap dimerization of the protein.

Authors:  Francesco Bonì; Mario Milani; Alberto Barbiroli; Luisa Diomede; Eloise Mastrangelo; Matteo de Rosa
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

3.  Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation.

Authors:  Sanjeev Sethi; Surendra Dasari; Emmanuelle Plaisier; Pierre Ronco; Samih H Nasr; Isabelle Brocheriou; Jason D Theis; Julie A Vrana; Michael T Zimmermann; Patrick S Quint; Ellen D McPhail; Paul J Kurtin
Journal:  Kidney Int Rep       Date:  2018-04-22

4.  The role of gelsolin domain 3 in familial amyloidosis (Finnish type).

Authors:  Habiba Zorgati; Mårten Larsson; Weitong Ren; Adelene Y L Sim; Jan Gettemans; Jonathan M Grimes; Wenfei Li; Robert C Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-26       Impact factor: 11.205

5.  A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation.

Authors:  Michela Bollati; Luisa Diomede; Toni Giorgino; Carmina Natale; Elisa Fagnani; Irene Boniardi; Alberto Barbiroli; Rebecca Alemani; Marten Beeg; Marco Gobbi; Ana Fakin; Eloise Mastrangelo; Mario Milani; Gianluca Presciuttini; Edi Gabellieri; Patrizia Cioni; Matteo de Rosa
Journal:  Comput Struct Biotechnol J       Date:  2021-11-19       Impact factor: 7.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.